Inventor · disambiguated record
Nelson S. Yew
Also filed as: YEW NELSON · YEW NELSON S
15 granted patents·13 pending applications·857 citations·filing 1995–2017
95Inventor score
Top patents by PatentIndex Score
28 records- 0196US5948767ACationic amphiphile/DNA complexesGENZYME CORP·Filed 1996·Granted Sep 7, 1999·271 cites·13 claims
- 0293US6066626ACompositions and method for treating lysosomal storage diseaseGENZYME CORP·Filed 1998·Granted May 23, 2000·154 cites·14 claims
- 0392US8003617B2Methods of treating diabetes mellitusGENZYME CORP·Filed 2005·Granted Aug 23, 2011·27 cites·50 claims
- 0492US6071890AOrgan-specific targeting of cationic amphiphile/DNA complexes for gene therapyGENZYME CORP·Filed 1995·Granted Jun 6, 2000·128 cites·14 claims
- 0591US8716327B2Methods of treating fatty liver diseaseZHAO HONGMEI·Filed 2007·Granted May 6, 2014·44 cites·12 claims
- 0689US5935936ACompositions comprising cationic amphiphiles and co-lipids for intracellular delivery of therapeutic moleculesGENZYME CORP·Filed 1996·Granted Aug 10, 1999·85 cites·20 claims
- 0786US8912177B2Method of treating polycystic kidney diseases with ceramide derivativesNATOLI THOMAS A·Filed 2008·Granted Dec 16, 2014·8 cites·13 claims
- 0885US6667174B2Expression vectors containing hybrid ubiquitin promotersGENZYME CORP·Filed 2001·Granted Dec 23, 2003·24 cites·11 claims
- 0984US7452716B2Expression vectors containing hybrid ubiquitin promotersGENZYME CORP·Filed 2003·Granted Nov 18, 2008·21 cites·20 claims
- 1083US9532976B2Method of lowering blood glucoseGENZYME CORP·Filed 2014·Granted Jan 3, 2017·5 cites·33 claims
- 1177US9556155B2Methods of treating fatty liver diseaseGENZYME CORP·Filed 2014·Granted Jan 31, 2017·3 cites·34 claims
- 1275US5910487ACationic amphiphiles and plasmids for intracellular delivery of therapeutic moleculesGENZYME CORP·Filed 1995·Granted Jun 8, 1999·28 cites·7 claims
- 1374US6383814B1Cationic amphiphiles for intracellular delivery of therapeutic moleculesGENZYME CORP·Filed 1999·Granted May 7, 2002·32 cites·16 claims
- 1472US5981275ATransgene expression system for increased persistenceGENZYME CORP·Filed 1997·Granted Nov 9, 1999·27 cites·4 claims
- 1568US2015216872A1Method of treating polycystic kidney diseases with ceramide derivativesGENZYME CORP·Filed 2014·Application pending·0 cites
- 1660US2010041151A1Compositions and methods for treating lysosomal storage diseaseGENZYME CORP·Filed 2008·Application pending·0 cites
- 1755US10220039B2Method of treating polycystic kidney diseases with ceramide derivativesGENZYME CORP·Filed 2017·Granted Mar 5, 2019·0 cites·10 claims
- 1855US2007238693A1Genetic modification of the lung as a portal for gene deliveryGENZYME CORP·Filed 2007·Application pending·0 cites
- 1951US2004053870A1CpG reduced plasmids and viral vectorsGENZYME CORP·Filed 2003·Application pending·0 cites
- 2050US2004110709A1Genetic modification of the lung as a portal for gene deliveryGENZYME CORP·Filed 2003·Application pending·0 cites
- 2149US2003087868A1Compositions and methods for treating lysosomal storage diseaseGENZYME CORP·Filed 2002·Application pending·0 cites
- 2249US2012022126A1Method Of Treating Diabetes MellitusCHENG SENG H·Filed 2011·Application pending·0 cites
- 2349US2017281593A1Methods of Treating Fatty Liver DiseaseGENZYME CORP·Filed 2016·Application pending·0 cites
- 2447US2016120956A1Composition of erythrocytes encapsulating phenylalanine hydroxylase and therapeutic use thereofERYTECH PHARMA·Filed 2014·Application pending·0 cites
- 2546US2003220277A1Methylation of plasmid vectorsGENZYME CORP·Filed 2002·Application pending·0 cites
- 2640US2002065236A1CpG reduced plasmids and viral vectorsFiled 2000·Application pending·0 cites
- 2739US2005176672A1Use of cationic lipids to generate anti-tumor immunitySTRESSGEN BIOTECHNOLOGIES·Filed 2005·Application pending·0 cites
- 2827US2002042383A1METHYLATION AND/Or CpG REMOVAL OF PLASMID VECTORSFiled 1999·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nelson S. Yew files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →